Arye Weigensberg - Cronos Senior Development
| CRON Stock | CAD 2.94 0.01 0.34% |
Executive
Arye Weigensberg is Senior Development of Cronos Group
| Age | 41 |
| Address | 111 Peter Street, Toronto, ON, Canada, M5V 2H1 |
| Phone | 416 504 0004 |
| Web | https://www.thecronosgroup.com |
Arye Weigensberg Latest Insider Activity
Tracking and analyzing the buying and selling activities of Arye Weigensberg against Cronos stock is an integral part of due diligence when investing in Cronos. Arye Weigensberg insider activity provides valuable insight into whether Cronos is net buyers or sellers over its current business cycle. Note, Cronos insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cronos'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Arye Weigensberg over six months ago Acquisition by Arye Weigensberg of 72 shares of Cronos subject to Rule 16b-3 |
Cronos Management Efficiency
The company has return on total asset (ROA) of (0.0373) % which means that it has lost $0.0373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0529) %, meaning that it generated substantial loss on money invested by shareholders. Cronos' management efficiency ratios could be used to measure how well Cronos manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to grow to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Cronos' Non Current Assets Total are very stable compared to the past year. As of the 28th of November 2024, Other Current Assets is likely to grow to about 6.2 M, while Total Assets are likely to drop about 809.1 M.Similar Executives
| Found 6 records | EXECUTIVE Age | ||
| Corinne Pruzanski | European Residential Real | N/A | |
| Scott Carroll | Cannara Biotech | N/A | |
| David Abitbol | Cannara Biotech | N/A | |
| Etienne Ledoux | Cannara Biotech | N/A | |
| Brian Sherman | Cannara Biotech | N/A | |
| France Landry | Cannara Biotech | N/A | |
Management Performance
| Return On Equity | -0.0529 | ||||
| Return On Asset | -0.0373 |
Cronos Group Leadership Team
Elected by the shareholders, the Cronos' board of directors comprises two types of representatives: Cronos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cronos. The board's role is to monitor Cronos' management team and ensure that shareholders' interests are well served. Cronos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cronos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arye Weigensberg, Senior Development | ||
| Shayne Laidlaw, Director Strategy | ||
| James III, Controller VP | ||
| James Holm, Chief Officer | ||
| Terry Doucet, General Secretary | ||
| Kevin Gifford, VP Fin | ||
| Anna Shlimak, Senior Strategy | ||
| Michael JD, CEO President | ||
| Carlos Cortez, Controller VP | ||
| Shannon Buggy, Senior People | ||
| Adam Wagner, Senior Israel | ||
| Jeffrey Jacobson, Vice President - Business Development |
Cronos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cronos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0529 | ||||
| Return On Asset | -0.0373 | ||||
| Profit Margin | (0.56) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | (92.75 M) | ||||
| Shares Outstanding | 382.3 M | ||||
| Shares Owned By Insiders | 46.40 % | ||||
| Shares Owned By Institutions | 15.61 % | ||||
| Number Of Shares Shorted | 4.57 M | ||||
| Price To Earning | 20.66 X |
Pair Trading with Cronos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.